• Clinicians are recommended to prescribe combination inhalers where appropriate, to improve overall adherence6 and to guarantee that a LABA is not taken without corticosteroid for asthma.6 
  • Incorporating this consideration into a respiratory review will also result in reduced overall carbon emissions as one inhaler is being used instead of two.

The chart below indicates those patients who may be considered for a combination inhaler, and all NHS Boards are improving. Please note that not all combination inhalers are licensed for both asthma and COPD. Please refer to individual Summary of Product Characteristics.


People prescribed inhalers as separate devices as a proportion of people prescribed any inhaler for which a combination inhaler may be appropriate


The numerical data for NTI graphs can also be viewed here.

The most up to date national therapeutic indicator data is available here.